0001104659-16-145309.txt : 20160919
0001104659-16-145309.hdr.sgml : 20160919
20160919070006
ACCESSION NUMBER: 0001104659-16-145309
CONFORMED SUBMISSION TYPE: 3/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160629
FILED AS OF DATE: 20160919
DATE AS OF CHANGE: 20160919
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Syros Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001556263
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 453772460
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 480 ARSENAL STREET
STREET 2: SUITE 130
CITY: WATERTOWN
STATE: MA
ZIP: 02472
BUSINESS PHONE: 617-744-1340
MAIL ADDRESS:
STREET 1: 480 ARSENAL STREET
STREET 2: SUITE 130
CITY: WATERTOWN
STATE: MA
ZIP: 02472
FORMER COMPANY:
FORMER CONFORMED NAME: LS22, Inc.
DATE OF NAME CHANGE: 20120815
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Patel Sanj K
CENTRAL INDEX KEY: 0001532218
FILING VALUES:
FORM TYPE: 3/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37813
FILM NUMBER: 161890715
MAIL ADDRESS:
STREET 1: 128 SPRING STREET, SUITE 520
CITY: LEXINGTON
STATE: MA
ZIP: 02421
3/A
1
a3a.xml
3/A
X0206
3/A
2016-06-29
2016-06-29
0
0001556263
Syros Pharmaceuticals, Inc.
SYRS
0001532218
Patel Sanj K
C/O SYROS PHARMACEUTICALS, INC.
620 MEMORIAL DRIVE, SUITE 300
CAMBRIDGE
MA
02139
1
0
0
0
Stock Option (right to buy)
11.66
2026-05-31
Common Stock
14666
D
The option becomes exercisable as to 25% of the shares underlying the award on June 1, 2017, with the remainder of the shares vesting in equal monthly installments thereafter through June 1, 2020.
This amendment to the Initial Statement of Beneficial Ownership of Securities on Form 3 filed with the Securities and Exchange Commission on June 29, 2016 is being filed to correct the omission of an option to purchase Common Stock held by the Reporting Person.
/s/ Kyle Kuvalanka, attorney-in-fact
2016-09-16